QEZ: Aspiration Thrombectomy Catheter
What it covers
To remove thrombus from the peripheral and/or coronary vasculature through aspiration.
FDA’s definition of product code QEZ, from the Product Classification database.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K254035 | Mayumi Thrombectomy System | MicroVention, Inc., d/b/a Terumo Neuro | Sep 3, 2026 | Traditional |
| K261105 | Powered Aventus Thrombectomy System | Inquis Medical | Jul 27, 2026 | Traditional |
| K262030 | Aventus Thrombectomy System | Inquis Medical | Jul 15, 2026 | Special |
| K253589 | Liberant RX Aspiration Catheter | Medtronic Interventional Vascular, Inc. | Apr 23, 2026 | Traditional |
| K254208 | FLOWRUNNER Aspiration System | Expanse Medical, Inc. | Mar 20, 2026 | Special |
| K253925 | Aventus Thrombectomy System | Inquis Medical | Jan 15, 2026 | Traditional |
| K252509 | AlphaVac Multipurpose Mechanical Aspiration System F1885 | AngioDynamics, Inc. | Nov 24, 2025 | Traditional |
| K251312 | Vesalio Peripheral System | Vesalio, Inc. | Oct 24, 2025 | Traditional |
| K251488 | FLOWRUNNER Aspiration System | Expanse Medical, Inc. | Jul 14, 2025 | Special |
| K243549 | JETi Hydrodynamic Thrombectomy System | ABBOTT MEDICAL | Apr 4, 2025 | Traditional |
Clearances by year
46 QEZ 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 6 | 98 |
| 2025 | 5 | 108 |
| 2024 | 1 | 52 |
| 2023 | 1 | 126 |
| 2022 | 2 | 128 |
| 2021 | 3 | 53 |
| 2020 | 3 | 120 |
| 2019 | 3 | 94 |
| 2018 | 1 | 25 |
| 2017 | 3 | 112 |
| 2016 | 1 | 111 |
| 2014 | 1 | 299 |
| 2013 | 4 | 144 |
| 2012 | 5 | 90 |
| 2011 | 7 | 118 |
Who submits
23 applicants cleared a QEZ device since 2011. 98% of the clearances went to applicants in United States, then India (2%). By type: Traditional 72% and Special 28%. 3 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| Walk Vascular, LLC | 9 |
| AngioDynamics, Inc. | 4 |
| Inquis Medical | 3 |
| Medrad, Inc. | 3 |
| Merit Medical Systems, Inc. | 3 |
| Vascular Solutions, Inc. | 3 |
| ABBOTT MEDICAL | 2 |
| Control Medical Technology, LLC | 2 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 870.5150.
Standards
21 CFR 870.5150 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent QEZ clearances declared.
Ask about QEZ
Questions about QEZ
What is FDA product code QEZ?
Product code QEZ, “Aspiration Thrombectomy Catheter” in FDA's classification database, is a Class II device type under 21 CFR 870.5150 (embolectomy catheter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 95 clearances under QEZ, 46 of them since 2011.
How many 510(k) clearances are there under QEZ?
FDA’s 510(k) database listed 95 clearances under QEZ as of Oct 29, 2026, 46 of them decided since 2011; the most recent decision was Sep 3, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a QEZ 510(k)?
For the 11 QEZ clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 108 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most QEZ clearances?
Since 2011: Walk Vascular, LLC (9), AngioDynamics, Inc. (4), Inquis Medical (3), Medrad, Inc. (3) and Merit Medical Systems, Inc. (3). 23 applicants have cleared a QEZ device in that time.